Upgrades & Downgrades

Format: 2015-07-30
Format: 21:09

Change in Ratings

Access Midstream upgraded at UBS
Dec 19, 2012 | 8:40 AM EST

ACMP was upgraded to Buy from Neutral, UBS said. $39 price target. Reassessing risk/reward. 

Bullish
CR Bard rated new Outperform at JMP
Dec 19, 2012 | 7:41 AM EST

BCR was initiated with an Outperform rating, JMP Securities said. $118 price target. Upcoming Gore settlement should be a near-term catalyst. 

Bearish
The Chubb Corporation downgraded at Morgan Stanley
Dec 19, 2012 | 8:05 AM EST

Shares of CB downgraded to Equal-weight from Overweight, Morgan Stanley said. Low yields constrain investment income growth.

Dunkin Brands upgraded at Miller Tabak
Dec 19, 2012 | 8:02 AM EST

DNKN was upgraded from Hold to Buy, Miller Tabak said. $38 price target. Company should see higher sales in the coming quarters.

 

Bullish
Energen rated new Buy at Wunderlich
Dec 19, 2012 | 6:50 AM EST

Coverage of EGN was started with a Buy rating, Wunderlich said. $56 price target. Permian basin should drive near-term growth. 

Bullish
Hartford Financial rated new Buy at MKM
Dec 19, 2012 | 8:31 AM EST

HIG was initiated with a Buy rating, MKM Partners said. $28 price target. Company is on the path toward higher returns. 

Bearish
H&R Block downgraded at Compass Point
Dec 19, 2012 | 6:46 AM EST

HRB was downgraded from Buy to Neutral, Compass Point said. Valuation call, based on a $19.50 price target. 

 

Bullish
Jarden rated new Overweight at JP Morgan
Dec 19, 2012 | 8:36 AM EST

Coverage of JAH was started with an Overweight rating, JP Morgan said. $62 price target. Company can expand margins and generate double-digit earnings growth. 

Medivation rated new Neutral at UBS
Dec 19, 2012 | 8:44 AM EST

MDVN was initiated with a Neutral rating, UBS said. $59 price target. Xtandi should drive conversion to profitability, but peak expectations high. 

ONYX Pharmaceutical rated new Buy at UBS
Dec 19, 2012 | 8:41 AM EST

ONXX was initiated with a Buy rating, UBS said. $97 price target. Well positioned in oncology. 

PDC Energy downgraded at Canaccord Genuity
Dec 19, 2012 | 8:06 AM EST

Shares of PDCE downgraded to Hold from Buy, Canaccord Genuity said. $34 price target. Utica prospect severely overbought.

Bullish
Quanta Services rated new Buy at UBS
Dec 19, 2012 | 8:46 AM EST

PWR was initiated with a Buy rating, UBS said. $32 price target. A healthy pipeline of opportunities. 

Update
Target rated new Hold at Stifel
Dec 19, 2012 | 8:26 AM EST

TGT was initiated with a Hold rating, Stifel Nicolaus said. New initiatives may take time to grab hold.

 

Bullish
Western Digital upgraded at Craig Hallum
Dec 19, 2012 | 8:27 AM EST

WDC was upgraded to Buy from Hold, Craig Hallum said. $54 price target. Estimate cuts in the near term have subsided. 

Stock Comments / EPS Changes

Bullish
Boeing added to Priority Stock List at Wells
Dec 19, 2012 | 8:29 AM EST

BA was placed on the Priority Stock list, Wells Fargo said. Company can return significant capital to shareholders over the next few years. 

Bearish
Baker Hughes numbers cut at Guggenheim
Dec 19, 2012 | 8:38 AM EST

Shares of BHI now seen reaching $48, according to Guggenheim. Estimates also reduced, given the company's new guidance. Neutral rating. 

Oracle numbers raised at Jefferies
Dec 19, 2012 | 7:57 AM EST

Shares of ORCL now seen reaching $35, Jefferies said. Estimates also raised on quarter beat. Hold rating.

Oracle numbers raised at Oppenheimer
Dec 19, 2012 | 7:59 AM EST

Shares of ORCL now seen reaching $37, Oppenheimer said. Estimates also raised on positive quarterly results. Outperform rating.

Oracle price target raised at Lazard
Dec 19, 2012 | 8:16 AM EST

ORCL price target raised to $41, Lazard said. Solid F2Q13 results that beat expectations. Buy rating. 

Bullish
Seagate Technology upgraded at Craig Hallum
Dec 19, 2012 | 8:32 AM EST

STX was upgraded to Buy from Hold, Craig Hallum said. $40 price target. Near term estimate cuts have subsided and inventory correction appears done. 

VeriSign added to Priority Stock List at Wells
Dec 19, 2012 | 8:25 AM EST

VRSN was added to the Priority Stock List at Wells Fargo. $44 to $47 price target. Attractive risk reward. 

Economics

Update
Housing Starts
Dec 19, 2012 | 6:26 AM EST

8:30am: Housing Starts, Nov., est. 871k (prior 894k)

Update
Building Permits
Dec 19, 2012 | 6:26 AM EST

8:30am: Building Permits, Nov., est. 875k (prior 868k)

Columnist Conversations

$455 million to sell on the close.
Market is giving back some of its gains of the last two sessions. With slightly over half of the S&P 500 r...
After three straight gains, on accelerating trade, PFE is pulling back. At yesterday's high the stock had ...
The IMF/Greece news triggers higher bond prices, lower yields.

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.